Net Loss Per Share (Tables)

9 Months Ended

Sep. 30, 2024

Earnings Per Share [Abstract]

Schedule of basic and diluted net loss per share

Basic and diluted net loss per share attributable to common shareholders of Biohaven was calculated as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Numerator:
Net loss	$	(160,304)	$	(102,574)	$	(659,579)	$	(263,412)
Denominator:
Weighted average common shares outstanding—basic and diluted	94,372,159		68,320,125		87,936,923		68,258,757
Net loss per share — basic and diluted	$	(1.70)	$	(1.50)	$	(7.50)	$	(3.86)

Schedule of potentially anti-dilutive securities excluded from calculation of diluted net loss per share

The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common shareholders for the periods indicated because including them would have had an anti-dilutive effect:

	As of September 30,
	2024	2023
Options to purchase common shares	13,094,018	9,740,921
Warrants to purchase common shares	294,195	—
Restricted share units	279,657	—
Total	13,667,870	9,740,921